Measuring circulating levels of microRNAs is a promising strategy for identifying people at risk of developing diabetes mellitus; however, several obstacles still need to be overcome before this strategy can be used in clinical practice. This Review summarizes the weaknesses of current biomarkers and discusses the potential use of microRNAs as novel biomarkers.
- Claudiane Guay
- Romano Regazzi